Lexicon Pharmaceuticals, Inc. Financial Ratios — LXRX Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	-42.68	-39.06	-47.67	-44.16	-1.64	-59.31	-109	- -	- -	-42.84	-65.01	-88.37	-168.5	-167.66	-39.72
Return on Assets (%)	-29.15	-27.47	-32.24	-26.91	-0.83	-23.31	-26.97	-33.45	37.08	-18.85	-51.52	-61.56	-83.6	-75.93	-20.83
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	100	100	100	100	100	100	97.93	96.06	99	91.96	100	100	92.94	98.02	99.45
EBITDA Margin (%)	-5,540.4	-8,662.81	-4,577.77	-367.15	9.01	-158.75	-136.47	-157.57	53.94	-732.87	-29,126.85	-72,182.01	-14,218.94	-632.49	-96.96
Operating Margin (%)	-5,804.71	-9,047.57	-4,706.62	-375.58	8.45	-161.34	-140.17	-163.39	52.81	-745.09	-29,224.83	-72,489.21	-14,264.95	-634.2	-98.21
Incremental Operating Margin (%)	- -	- -	- -	- -	90.36	- -	- -	- -	105.6	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-6,285.29	-10,120.39	-4,686.14	-439.15	-3.6	-165.85	-147.95	-190.71	38.54	-244.11	-29,448.99	-73,341.01	-14,710.88	-644.78	-101.08
Profit Margin (%)	-6,285.29	-10,120.39	-4,686.14	-438.85	-3.6	-165.85	-134.14	-190.71	40.4	-244.11	-29,448.99	-73,341.01	-14,710.88	-644.78	-101.08
Net Income to Common Margin (%)	-6,285.29	-10,120.39	-4,686.14	-438.85	-3.6	-165.85	-134.14	-190.71	40.4	-244.11	-29,448.99	-73,341.01	-14,710.88	-644.78	-101.08
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	-42.68	-39.06	-47.67	-44.16	-1.64	-59.31	-109	- -	- -	-42.84	-65.01	-88.37	-168.5	-167.66	-39.72

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	25	23	22	108	103	101	246	245	246	13	2	55	106	108	63
ST Debt	1	2	2	20	2	16	14	1	12	12	1	1	1	1	6
LT Debt	23	22	20	88	101	85	232	244	234	1	1	54	105	107	57
Total Debt/EBITDA	-0.24	-0.25	-0.22	-1.28	8.78	-0.81	-1.96	-2.46	1.41	-0.07	-0.03	-0.55	-0.62	-0.55	-1.3
Net Debt/EBITDA	1.58	0.07	0.15	0.35	-8.54	-0.44	-1.47	-1.65	1.2	0.65	0.74	-0.02	-0.45	-0.17	-0.41
Total Debt/EBIT	-0.23	-0.24	-0.21	-1.25	9.36	-0.79	-1.91	-2.37	1.44	-0.07	-0.03	-0.55	-0.62	-0.55	-1.28
Net Debt/EBIT	1.5	0.07	0.15	0.34	-9.1	-0.43	-1.43	-1.59	1.23	0.64	0.74	-0.02	-0.45	-0.17	-0.4
EBITDA to Interest Expense	-40.52	-44.63	-51.61	-37.24	1.74	-19.16	-17.92	-4.79	8.4	-12.09	-108.23	-36.09	-13.07	-12.62	-5.79
EBITDA-CapEx/Interest Expense	-41	-44.86	-52.48	-37.28	1.61	-19.19	-17.95	-4.8	8.4	-12.1	-109.75	-36.57	-13.1	-12.68	-5.79
EBIT to Interest Expense	-42.46	-46.61	-53.06	-38.1	1.64	-19.47	-18.4	-4.97	8.23	-12.29	-108.59	-36.24	-13.11	-12.65	-5.87
Interest Expense	3	2	2	2	7	7	7	21	21	15	1	3	13	16	8
Common Equity/Total Assets	69.12	71.73	62.07	60.25	43.84	33.09	15.64	-9.29	28.03	76.73	82.97	60.28	40.58	48.91	58.13
Long-Term Debt/Equity (%)	7.88	8.2	11.85	30.81	35.32	54.11	339.23	- -	199.97	0.39	1.05	46.11	112.53	73.46	52.62
Long-Term Debt/Capital (%)	7.27	7.54	10.5	22.34	25.97	32.9	73.77	111.57	64.54	0.36	1.03	31.32	52.6	42.16	33.21
Long-Term Debt/Total Assets (%)	5.45	5.88	7.36	18.56	15.49	17.91	53.05	85.83	56.06	0.3	0.87	27.79	45.67	35.93	30.59
Total Debt/Equity (%)	8.37	8.79	12.86	37.91	36.01	64.45	359.88	-927.86	209.85	8.19	2.01	47.21	113.91	74.27	58.42
Total Debt/Capital (%)	7.72	8.08	11.39	27.49	26.48	39.19	78.26	112.08	67.73	7.57	1.97	32.07	53.25	42.62	36.87
Total Debt/Total Assets (%)	5.78	6.31	7.98	22.84	15.79	21.33	56.28	86.23	58.83	6.29	1.66	28.46	46.23	36.32	33.96
Net Debt to Equity	-54.24	-2.61	-9.18	-10.42	-35	34.85	269.55	-623.43	178.54	-73.3	-56.4	1.91	82.74	23.05	18.3
Net Debt/Capital (%)	-118.55	-2.68	-10.11	-11.63	-53.85	25.84	72.94	119.1	63.99	-267.06	-123.66	1.77	43.6	17.92	14.47
EBITDA	-102	-94	-102	-84	12	-126	-125	-100	174	-176	-87	-100	-171	-197	-48
EBITDA-CapEx	-104	-95	-103	-84	11	-126	-125	-100	174	-176	-88	-102	-172	-198	-48
Operating Income (Loss)	-107	-99	-105	-86	11	-128	-129	-103	170	-179	-87	-101	-172	-197	-49

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	13.17	12.21	6.69	7.55	4.24	2.1	2.95	4.36	4.16	3.25	3.92	5.97	5.39	5.26	4.61
Current Ratio	13.36	12.63	6.97	8.21	4.33	2.17	3.05	4.72	5.17	3.37	4.02	6.08	5.6	5.44	4.88
Quick Ratio	13.19	12.28	6.73	7.57	4.25	2.15	2.99	4.52	5.02	3.26	3.92	5.97	5.42	5.34	4.73
CFO/Avg Current Liab	-5.47	-4.76	-4.85	-2.35	2.2	-1.22	-1.37	-2.09	2.23	-2.55	-2.52	-3.92	-5.92	-4.66	-2.05
Common Equity/Total Assets	69.12	71.73	62.07	60.25	43.84	33.09	15.64	-9.29	28.03	76.73	82.97	60.28	40.58	48.91	58.13
Long-Term Debt/Equity (%)	7.88	8.2	11.85	30.81	35.32	54.11	339.23	- -	199.97	0.39	1.05	46.11	112.53	73.46	52.62
Long-Term Debt/Capital (%)	7.27	7.54	10.5	22.34	25.97	32.9	73.77	111.57	64.54	0.36	1.03	31.32	52.6	42.16	33.21
Long-Term Debt/Total Assets (%)	5.45	5.88	7.36	18.56	15.49	17.91	53.05	85.83	56.06	0.3	0.87	27.79	45.67	35.93	30.59
Total Debt/Equity (%)	8.37	8.79	12.86	37.91	36.01	64.45	359.88	-927.86	209.85	8.19	2.01	47.21	113.91	74.27	58.42
Total Debt/Capital (%)	7.72	8.08	11.39	27.49	26.48	39.19	78.26	112.08	67.73	7.57	1.97	32.07	53.25	42.62	36.87
Total Debt/Total Assets (%)	5.78	6.31	7.98	22.84	15.79	21.33	56.28	86.23	58.83	6.29	1.66	28.46	46.23	36.32	33.96
CFO/Total Liabilities	-66.15	-89.88	-87.58	-40.36	50.47	-55.19	-50.34	-47.85	37.86	-301.51	-373.24	-115.13	-118.76	-117.26	-87.61
CFO/CapEx	-72.92	-191.99	-52.92	-945.28	203.05	-760.29	-813.13	-1,564.28	1,625.81	-1,643.32	-71.27	-67.01	-344.46	-173.4	- -
Altman's Z-Score	-0.64	1.61	-3.81	-1.68	0.65	-2.21	-4.13	-10.11	-1.01	-8.9	-9.69	-13.34	-13.85	-11.29	-16.98

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	3.38	1.26	2.05	25.05	133.62	18.86	14.89	11.76	10.31	0.84	1.46	6.62	2.32	13.87	17.01
Days Sales Outstanding	107.98	289.59	178.06	14.57	2.73	19.35	24.52	31.04	35.39	432.97	250.48	55.14	157.34	26.32	21.46
Inventory Turnover	- -	- -	- -	- -	- -	- -	1.95	0.75	0.72	0.91	- -	- -	0.45	2.01	1.07
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	187.21	485.59	504.01	401.42	- -	- -	818.03	181.31	341.02
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	0.08	0.21	0.23	-0.26	- -	- -	0.04	0.03	0.04
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	4,347.31	1,775.52	1,582.67	-1,391.78	- -	- -	9,706.18	11,431.71	10,073.55
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	-4,135.59	-1,258.9	-1,043.27	2,226.18	- -	- -	-8,730.81	-11,224.07	-9,711.06
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	-162.69	-454.56	-468.62	31.55	- -	- -	-660.69	-154.99	-319.56
Inventories	- -	- -	- -	- -	- -	- -	2	5	4	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	1	4	3	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	1	1	1	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	619	1,132	924	659	1,379	1,442	1,043	703	441	484	587	360	375	267	418
- Cash & Cash Equivalents	186	30	37	137	203	47	62	80	36	126	64	46	22	67	34
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	25	23	22	108	103	101	246	245	246	13	2	55	106	108	63
Enterprise Value	363	933	817	427	961	1,197	978	788	415	344	502	277	311	137	385
Total Capital	322	290	192	392	389	259	314	219	363	169	116	172	199	254	170
Total Debt/Capital (%)	7.72	8.08	11.39	27.49	26.48	39.19	78.26	112.08	67.73	7.57	1.97	32.07	53.25	42.62	36.87
Total Debt / EV	0.07	0.03	0.03	0.25	0.11	0.08	0.25	0.31	0.59	0.04	- -	0.2	0.34	0.79	0.16
EV/Sales	196.12	856.37	367.74	18.71	7.39	15.1	10.67	12.47	1.29	14.36	1,685.47	1,995.71	258.12	4.42	7.72
EV/EBITDA	- -	- -	- -	- -	81.99	- -	- -	- -	2.39	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	87.41	- -	- -	- -	2.44	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	5.02	- -	- -	- -	3.06	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	4.99	- -	- -	- -	3.06	- -	- -	- -	- -	- -	- -
Diluted Market Cap	440	1,082	924	486	1,379	1,436	1,040	703	485	379	574	317	338	236	418
Diluted Enterprise Value	278	1,075	908	457	1,279	1,491	1,224	867	694	266	512	325	422	278	446
EV per Share	5.29	12.74	11.14	4.13	9.27	11.48	9.26	7.44	3.91	2.43	3.37	1.47	1.27	0.38	1.06
TTM Sales	2	1	2	23	130	79	92	63	322	24	- -	- -	1	31	50
TTM EBITDA	-102	-94	-102	-84	12	-126	-125	-100	174	-176	-87	-100	-171	-197	-48
TTM Operating Income	-107	-99	-105	-86	11	-128	-129	-103	170	-179	-87	-101	-172	-197	-49
TTM Cash Flow to Firm	-85	-92	-89	-73	191	-169	-179	-128	135	-128	-86	-86	-149	-163	-60
TTM Free Cash Flow to Firm	-84	-92	-87	-73	192	-169	-179	-128	136	-128	-85	-85	-148	-162	-60

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	-5.07	-11.52	-10.34	-6.44	7.43	-8.19	-5.62	-4.73	4.25	-2.65	-6.69	-3.62	-2.1	-1.33	-6.15
EV/EBIT	- -	- -	- -	- -	87.41	- -	- -	- -	2.44	- -	- -	- -	- -	- -	- -
Enterprise Value	363	933	817	427	961	1,197	978	788	415	344	502	277	311	137	385
Low Price	5.67	7.91	11.9	5.6	6.09	7.65	8.07	6.02	1.13	1.03	3.26	1.31	0.92	0.62	0.28
EV/Sales	196.12	856.37	367.74	18.71	7.39	15.1	10.67	12.47	1.29	14.36	1,685.47	1,995.71	258.12	4.42	7.72
EV/EBITDA	- -	- -	- -	- -	81.99	- -	- -	- -	2.39	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	3.39	- -	- -	- -	- -	- -	- -
Price/Earnings Average	-4.38	-8.64	-11.08	-8.02	-207.65	-11.13	-11.86	-8.57	3.87	-4.07	-8.56	-3.9	-2.46	-2.76	-6.88
Price/Earnings High	-6.74	-14.57	-15.67	-10.98	-349.36	-15.5	-15.4	-12.26	6.85	-8.46	-16.02	-6.49	-4.73	-5.96	-11.97
Price/Earnings Low	-2.38	-5.02	-8.38	-4.26	-134.74	-6.04	-6.9	-5.29	0.92	-1.95	-5.41	-2.13	-1.15	-0.99	-2.05
Price/Book Value	2.08	4.25	5.43	2.32	4.82	9.16	15.28	-26.64	3.77	3.09	5.17	3.08	4.02	1.83	3.89
Price/Book Value Average	2.41	3.74	6.79	3.84	3.4	9.33	21.45	-39.17	4.3	1.95	6.76	3.86	5.18	4.28	3.23
Price/Book Value High	3.71	6.3	9.6	5.25	5.72	13	27.84	-56.04	7.61	4.04	12.65	6.43	9.97	9.24	5.61
Price/Book Value Low	1.31	2.17	5.13	2.04	2.21	5.07	12.48	-24.15	1.03	0.93	4.27	2.11	2.42	1.54	0.96
Price/Tangible Book Value	3.11	6.72	12.83	3.54	7.34	24.24	-37.04	-5.81	8.35	4.33	8.5	4.97	7.72	2.63	6.64
Price/Tangible Book Value Average	3.6	5.91	16.03	5.86	5.17	24.68	-51.99	-8.54	9.53	2.72	11.12	6.23	9.93	6.17	5.51
Price/Tangible Book Value High	5.54	9.97	22.66	8.02	8.71	34.38	-67.49	-12.22	16.87	5.66	20.81	10.37	19.11	13.3	9.58
Price/Tangible Book Value Low	1.95	3.43	12.11	3.11	3.36	13.41	-30.26	-5.27	2.27	1.3	7.03	3.41	4.64	2.21	1.64
Price/Sales	237.74	993.8	415.67	21.28	10.6	18.12	11.34	11.12	1.37	15.8	1,925.73	2,277.34	281	7.6	8.38
Price/Sales Average	275.34	874.85	519.33	35.2	7.48	18.45	15.91	16.35	1.56	9.93	2,520.07	2,856.64	361.53	17.81	6.96
Price/Sales High	423.88	1,474.97	734.34	48.17	12.58	25.71	20.66	23.39	2.77	20.65	4,716.58	4,757.37	696.08	38.41	12.1
Price/Sales Low	149.28	508.14	392.57	18.71	4.85	10.03	9.26	10.08	0.37	4.76	1,593.37	1,561.94	168.97	6.39	2.07
Price/Cash Flow	-5	-11.46	-10.14	-6.43	7.46	-8.18	-5.61	-4.73	3.87	-2.65	-6.59	-3.56	-2.09	-1.32	-6.15
Price/Cash Flow Average	-5.79	-10.09	-12.67	-10.64	5.26	-8.33	-7.87	-6.95	4.42	-1.67	-8.63	-4.47	-2.69	-3.1	-5.11
Price/Cash Flow High	-8.91	-17	-17.92	-14.56	8.85	-11.6	-10.22	-9.95	7.83	-3.47	-16.15	-7.44	-5.18	-6.68	-8.88
Price/Cash Flow Low	-3.14	-5.86	-9.58	-5.65	3.41	-4.52	-4.58	-4.29	1.05	-0.8	-5.46	-2.44	-1.26	-1.11	-1.52
Price/Free Cash Flow Average	-5.87	-10.14	-12.91	-10.65	5.24	-8.34	-7.88	-6.96	4.86	-1.67	-8.75	-4.54	-2.7	-3.11	-5.11
Price/Free Cash Flow High	-9.04	-17.09	-18.26	-14.57	8.81	-11.62	-10.23	-9.96	8.6	-3.47	-16.38	-7.56	-5.19	-6.72	-8.88
Price/Free Cash Flow Low	-3.18	-5.89	-9.76	-5.66	3.4	-4.53	-4.59	-4.29	1.16	-0.8	-5.53	-2.48	-1.26	-1.12	-1.52
EV/Sales Average	300.69	908.95	512.72	46.42	6.71	19.22	17.97	18.97	2.21	7.95	2,369.22	3,317.33	469.86	21.46	7.54
EV/Sales High	509.99	1,536.84	727.91	64	11.82	26.51	22.74	26.02	3.42	21.63	4,614.98	5,481.77	840.42	44.73	12.69
EV/Sales Low	123.05	525.26	385.86	24.06	4.08	10.76	11.3	12.69	1.02	1.35	1,421.76	1,843.02	256.59	8.56	2.64
EV/EBITDA Average	-5.43	-10.49	-11.2	-12.64	74.45	-12.11	-13.17	-12.04	4.1	-1.08	-8.13	-4.6	-3.3	-3.39	-7.77
EV/EBITDA High	-9.2	-17.74	-15.9	-17.43	131.08	-16.7	-16.66	-16.51	6.34	-2.95	-15.84	-7.59	-5.91	-7.07	-13.08
EV/EBITDA Low	-2.22	-6.06	-8.43	-6.55	45.31	-6.78	-8.28	-8.06	1.9	-0.18	-4.88	-2.55	-1.8	-1.35	-2.72
EV/EBIT Average	-5.18	-10.05	-10.89	-12.36	79.37	-11.91	-12.82	-11.61	4.19	-1.07	-8.11	-4.58	-3.29	-3.38	-7.67
EV/EBIT High	-8.79	-16.99	-15.47	-17.04	139.75	-16.43	-16.22	-15.92	6.47	-2.9	-15.79	-7.56	-5.89	-7.05	-12.92
EV/EBIT Low	-2.12	-5.81	-8.2	-6.41	48.31	-6.67	-8.06	-7.77	1.94	-0.18	-4.86	-2.54	-1.8	-1.35	-2.69
Last Price	9.03	15.47	12.6	6.37	13.31	13.83	9.88	6.64	4.15	3.42	3.94	1.91	1.53	0.74	1.15
High Price	16.1	22.96	22.26	14.42	15.79	19.62	18	13.97	8.39	4.47	9.65	3.99	3.79	3.73	1.66
Enterprise Value Average	556	990	1,139	1,061	872	1,523	1,648	1,199	713	191	706	461	566	667	375
Enterprise Value High	943	1,674	1,617	1,463	1,536	2,101	2,085	1,644	1,101	519	1,375	762	1,012	1,390	632
Enterprise Value Low	228	572	857	550	531	853	1,036	802	330	32	424	256	309	266	132

Shares Outstanding	69	73	73	103	104	104	106	106	106	141	149	189	245	361	363
Diluted Weighted Avg Shares	49	70	73	76	104	104	105	106	117	111	146	166	221	320	363
Basic Weighted Avg Shares	49	70	73	76	104	104	105	106	106	111	146	166	221	320	363
Revenue per Share	0.04	0.02	0.03	0.3	1.26	0.76	0.87	0.6	3.03	0.22	- -	- -	0.01	0.1	0.14
EBITDA per Share	-2.1	-1.35	-1.39	-1.1	0.11	-1.21	-1.19	-0.94	1.64	-1.59	-0.6	-0.61	-0.77	-0.61	-0.13
Operating Income per Share	-2.2	-1.41	-1.43	-1.12	0.11	-1.23	-1.22	-0.98	1.6	-1.61	-0.6	-0.61	-0.78	-0.62	-0.13
Basic EPS, GAAP	-2.39	-1.58	-1.42	-1.31	-0.05	-1.27	-1.17	-1.14	1.23	-0.53	-0.6	-0.62	-0.8	-0.63	-0.14
Basic EPS from Cont Ops	-2.39	-1.58	-1.42	-1.31	-0.05	-1.27	-1.17	-1.14	1.23	-0.53	-0.6	-0.62	-0.8	-0.63	-0.14
Diluted EPS, GAAP	-2.39	-1.58	-1.42	-1.31	-0.05	-1.27	-1.17	-1.14	1.11	-0.53	-0.6	-0.62	-0.8	-0.63	-0.14
Diluted EPS from Cont Ops	-2.39	-1.58	-1.42	-1.31	-0.05	-1.27	-1.17	-1.14	1.11	-0.53	-0.6	-0.62	-0.8	-0.63	-0.14
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-1.81	-1.35	-1.24	-0.99	1.78	-1.69	-1.76	-1.4	1.07	-1.29	-0.6	-0.54	-0.73	-0.56	-0.19
Free Cash Flow per Basic Share	-1.83	-1.36	-1.27	-0.99	1.77	-1.69	-1.76	-1.41	1.07	-1.29	-0.61	-0.54	-0.73	-0.56	-0.19
Cash & Equivalents per Share	4.11	3.05	1.76	3.28	5.03	3.32	2.94	1.51	2.56	1.08	0.58	0.73	0.69	0.66	0.26
Book Value per Share	4.34	3.64	2.32	2.74	2.76	1.51	0.65	-0.25	1.1	1.11	0.76	0.62	0.38	0.4	0.3
Tangible Book Value per Share	2.91	2.3	0.98	1.8	1.81	0.57	-0.27	-1.14	0.5	0.79	0.46	0.38	0.2	0.28	0.17

Lexicon Pharmaceuticals, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)